Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Stroop test performance in impulsive and non impulsive patients with Parkinson's disease.

Djamshidian A, O'Sullivan SS, Lees A, Averbeck BB.

Parkinsonism Relat Disord. 2011 Mar;17(3):212-4. doi: 10.1016/j.parkreldis.2010.12.014. Epub 2011 Jan 17.

2.

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.

Djamshidian A, Jha A, O'Sullivan SS, Silveira-Moriyama L, Jacobson C, Brown P, Lees A, Averbeck BB.

Mov Disord. 2010 Oct 15;25(13):2203-10. doi: 10.1002/mds.23247.

3.

Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour.

Djamshidian A, O'Sullivan SS, Doherty K, Lees AJ, Averbeck BB.

Neuropsychologia. 2011 Jan;49(1):103-7. doi: 10.1016/j.neuropsychologia.2010.10.012. Epub 2010 Oct 19.

4.

Dissociable Effects of Dopamine on the Initial Capture and the Reactive Inhibition of Impulsive Actions in Parkinson's Disease.

van Wouwe NC, Kanoff KE, Claassen DO, Spears CA, Neimat J, van den Wildenberg WP, Wylie SA.

J Cogn Neurosci. 2016 May;28(5):710-23. doi: 10.1162/jocn_a_00930. Epub 2016 Feb 2.

5.

Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.

Huang YT, Georgiev D, Foltynie T, Limousin P, Speekenbrink M, Jahanshahi M.

Neuropsychologia. 2015 Aug;75:577-87. doi: 10.1016/j.neuropsychologia.2015.07.012. Epub 2015 Jul 13.

PMID:
26184442
6.

Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.

Leroi I, Barraclough M, McKie S, Hinvest N, Evans J, Elliott R, McDonald K.

J Neuropsychol. 2013 Sep;7(2):306-25. doi: 10.1111/jnp.12026. Epub 2013 Jul 31.

PMID:
23901888
7.

Impulsive choice and response in dopamine agonist-related impulse control behaviors.

Voon V, Reynolds B, Brezing C, Gallea C, Skaljic M, Ekanayake V, Fernandez H, Potenza MN, Dolan RJ, Hallett M.

Psychopharmacology (Berl). 2010 Jan;207(4):645-59. doi: 10.1007/s00213-009-1697-y. Epub 2009 Oct 20.

8.

Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease.

Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB.

Brain. 2014 Apr;137(Pt 4):1145-55. doi: 10.1093/brain/awu032. Epub 2014 Feb 27.

9.

Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?

van Stockum S, MacAskill M, Anderson T, Dalrymple-Alford J.

Neuropsychologia. 2008 Nov;46(13):3108-15. doi: 10.1016/j.neuropsychologia.2008.07.002. Epub 2008 Jul 12.

PMID:
18674551
10.

Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?

Djamshidian A, O'Sullivan SS, Sanotsky Y, Sharman S, Matviyenko Y, Foltynie T, Michalczuk R, Aviles-Olmos I, Fedoryshyn L, Doherty KM, Filts Y, Selikhova M, Bowden-Jones H, Joyce E, Lees AJ, Averbeck BB.

Mov Disord. 2012 Aug;27(9):1137-45. doi: 10.1002/mds.25105. Epub 2012 Jul 20.

11.

Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease.

O'Sullivan SS, Loane CM, Lawrence AD, Evans AH, Piccini P, Lees AJ.

J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):620-2. doi: 10.1136/jnnp.2009.186874. Epub 2010 Jun 20.

PMID:
20566476
12.

The Prague Stroop Test: Normative standards in older Czech adults and discriminative validity for mild cognitive impairment in Parkinson's disease.

Bezdicek O, Lukavsky J, Stepankova H, Nikolai T, Axelrod BN, Michalec J, Růžička E, Kopecek M.

J Clin Exp Neuropsychol. 2015;37(8):794-807. doi: 10.1080/13803395.2015.1057106.

PMID:
26313510
13.

Novelty seeking behaviour in Parkinson's disease.

Djamshidian A, O'Sullivan SS, Wittmann BC, Lees AJ, Averbeck BB.

Neuropsychologia. 2011 Jul;49(9):2483-8. doi: 10.1016/j.neuropsychologia.2011.04.026. Epub 2011 May 4.

14.

Fronto-striatal atrophy correlates of inhibitory dysfunction in Parkinson's disease versus behavioural variant frontotemporal dementia.

O'Callaghan C, Naismith SL, Hodges JR, Lewis SJ, Hornberger M.

Cortex. 2013 Jul-Aug;49(7):1833-43. doi: 10.1016/j.cortex.2012.12.003. Epub 2012 Dec 12.

PMID:
23306064
15.

Identifying the Basal Ganglia network model markers for medication-induced impulsivity in Parkinson's disease patients.

Balasubramani PP, Chakravarthy VS, Ali M, Ravindran B, Moustafa AA.

PLoS One. 2015 Jun 4;10(6):e0127542. doi: 10.1371/journal.pone.0127542. eCollection 2015.

16.

Deep brain stimulation and behavioural changes: is comedication the most important factor?

Lulé D, Heimrath J, Pinkhardt EH, Ludolph AC, Uttner I, Kassubek J.

Neurodegener Dis. 2012;9(1):18-24. doi: 10.1159/000328817. Epub 2011 Jul 21.

PMID:
21778695
17.

Are there ethnic differences in impulsive/compulsive behaviors in Parkinson's disease?

Chiang HL, Huang YS, Chen ST, Wu YR.

Eur J Neurol. 2012 Mar;19(3):494-500. doi: 10.1111/j.1468-1331.2011.03571.x. Epub 2011 Oct 31.

PMID:
22040282
18.

Impulsive oculomotor action selection in Parkinson's disease.

Duprez J, Houvenaghel JF, Argaud S, Naudet F, Robert G, Drapier D, Vérin M, Sauleau P.

Neuropsychologia. 2017 Jan 27;95:250-258. doi: 10.1016/j.neuropsychologia.2016.12.027. Epub 2016 Dec 28.

19.

Sleep and impulsivity in Parkinson's disease.

Scullin MK, Sollinger AB, Land J, Wood-Siverio C, Zanders L, Lee R, Freeman A, Goldstein FC, Bliwise DL, Factor SA.

Parkinsonism Relat Disord. 2013 Nov;19(11):991-4. doi: 10.1016/j.parkreldis.2013.06.018. Epub 2013 Jul 21.

20.

Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions.

Antonelli F, Ko JH, Miyasaki J, Lang AE, Houle S, Valzania F, Ray NJ, Strafella AP.

Hum Brain Mapp. 2014 Jun;35(6):2499-506. doi: 10.1002/hbm.22344. Epub 2013 Sep 3.

Supplemental Content

Support Center